Short Information | Taiwan Liposome Company Ltd. (NASDAQ:TLC)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 32,812 |
Total Actual Volume | 293,171 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,641 |
Average Short Percentage | 10.09% |
Is there a TLC Short Squeeze or Breakout about to happen?
See the TLC Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
09-24-2021 | $6.82 | $7.01 | $7.01 | $6.82 | 19,223 | 1,418 | 7.38% |
09-23-2021 | $6.85 | $7.08 | $7.08 | $6.85 | 10,363 | 1,445 | 13.94% |
09-22-2021 | $6.9 | $6.9287 | $7.0726 | $6.8201 | 7,851 | 1,171 | 14.92% |
09-21-2021 | $7 | $6.9449 | $7 | $6.82 | 6,828 | 1,026 | 15.03% |
09-20-2021 | $7.3 | $7.1 | $7.3 | $6.9796 | 9,542 | 1,435 | 15.04% |
09-17-2021 | $6.95 | $7.25 | $7.25 | $6.65 | 22,269 | 4,563 | 20.49% |
09-16-2021 | $7.18 | $7.0406 | $7.2487 | $6.95 | 15,203 | 3,287 | 21.62% |
09-15-2021 | $7.08 | $7.24 | $7.35 | $7.08 | 4,462 | 206 | 4.62% |
09-14-2021 | $7.1 | $7.1596 | $7.1596 | $7 | 8,580 | 654 | 7.62% |
09-13-2021 | $7.33 | $7 | $7.33 | $7 | 28,799 | 7,910 | 27.47% |
09-10-2021 | $7.0001 | $7.32 | $7.32 | $7.0001 | 15,001 | 2,905 | 19.37% |
09-09-2021 | $7.1 | $7 | $7.1 | $7 | 10,352 | 252 | 2.43% |
09-08-2021 | $7.25 | $7.15 | $7.3307 | $7.1 | 8,097 | 8 | 0.1% |
09-07-2021 | $7.59 | $7.35 | $7.59 | $7.28 | 2,687 | 20 | 0.74% |
09-03-2021 | $7.69 | $7.53 | $7.69 | $7.4901 | 11,544 | 381 | 3.3% |
09-01-2021 | $7.52 | $7.6273 | $7.7 | $7.4701 | 8,845 | 470 | 5.31% |
08-31-2021 | $7.27 | $7.44 | $7.54 | $7.27 | 76,167 | 3,796 | 4.98% |
08-30-2021 | $7.21 | $7.2 | $7.23 | $7.1 | 5,705 | 350 | 6.13% |
08-25-2021 | $7.1 | $7.07 | $7.1 | $7.04 | 8,225 | 14 | 0.17% |
08-24-2021 | $7 | $7.08 | $7.09 | $6.98 | 13,428 | 1,501 | 11.18% |
News, Short Squeeze, Breakout and More Instantly...
Taiwan Liposome Company Ltd. Company Name:
TLC Stock Symbol:
NASDAQ Market:
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Professor David Hunter, Florance and Cope Chair of Rheumatology at the University of Sydney, presented detailed findings from the Phase 3 clinical trial of TLC599 at the American College of Rheumatology (ACR) Annual...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a late clinical-stage specialty pharma...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a late clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical needs in orthopedic disorders, today announced that the Abstract Sele...